Veterans Affairs Cooperative Studies Program Study 553: Chemotherapy After Prostatectomy, a Phase III Randomized Study of Prostatectomy Versus Prostatectomy with Adjuvant Docetaxel for Patients with High-Risk, Localized Prostate Cancer - 08/08/11

Bruce Montgomery ^{a, ⁎} , Philip Lavori ^b, Mark Garzotto ^c, Kelvin Lee ^d, Mary Brophy ^e, Surai Thaneemit-Chen ^d, William Kelly ^f, Joseph Basler ^g, Robert Ringer ^h, Wei Yu ^d, Alice Whittemore ^b, Daniel W. Lin ^a

^a Veterans Affairs Puget Sound Health Care System and University of Washington, Seattle, Washington 

^b Department of Health Research and Policy, Stanford University, Stanford, California 

^c Division of Urology, Department of Surgery, Veterans Affairs Portland and Oregon Health and Sciences University, Portland, Oregon 

^d Veterans Affairs Cooperative Studies Coordinating Center, Palo Alto, California 

^e Massachusetts Veterans Epidemiology Research and Information Center, Boston, Massachusetts 

^f Division of Oncology, Department of Medicine, Yale University, New Haven, Connecticut 

^g South Texas Veterans Administration Health Care System and Department of Urology, University of Texas Health Sciences Center, San Antonio, Texas 

^h Cooperative Studies Pharmacy Coordinating Center, Albuquerque, New Mexico 

Reprint requests: Bruce Montgomery, M.D., Division of Medical Oncology, S-111-ONC, Veterans Affairs Puget Sound Health Care System, 1660 South Columbian Way, Seattle, WA 98109